- Home
- ILAG vs ALBT Comparison
ILAG vs ALBT Comparison
Compare ILAG & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- ALBT
- Stock Information
- Founded
- ILAG 1981
- ALBT 2014
- Country
- ILAG Hong Kong
- ALBT United States
- Employees
- ILAG N/A
- ALBT N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ILAG Consumer Discretionary
- ALBT Health Care
- Exchange
- ILAG Nasdaq
- ALBT Nasdaq
- Market Cap
- ILAG 18.4M
- ALBT 2.9M
- IPO Year
- ILAG 2022
- ALBT N/A
- Fundamental
- Price
- ILAG $0.98
- ALBT $0.20
- Analyst Decision
- ILAG
- ALBT
- Analyst Count
- ILAG 0
- ALBT 0
- Target Price
- ILAG N/A
- ALBT N/A
- AVG Volume (30 Days)
- ILAG 47.1K
- ALBT 639.6K
- Earning Date
- ILAG 11-29-2024
- ALBT 11-12-2024
- Dividend Yield
- ILAG N/A
- ALBT N/A
- EPS Growth
- ILAG N/A
- ALBT N/A
- EPS
- ILAG N/A
- ALBT N/A
- Revenue
- ILAG $6,443,357.00
- ALBT N/A
- Revenue This Year
- ILAG N/A
- ALBT N/A
- Revenue Next Year
- ILAG N/A
- ALBT N/A
- P/E Ratio
- ILAG N/A
- ALBT N/A
- Revenue Growth
- ILAG N/A
- ALBT N/A
- 52 Week Low
- ILAG $0.33
- ALBT $0.16
- 52 Week High
- ILAG $1.35
- ALBT $1.44
- Technical
- Relative Strength Index (RSI)
- ILAG 44.56
- ALBT 42.61
- Support Level
- ILAG $0.97
- ALBT $0.16
- Resistance Level
- ILAG $1.06
- ALBT $0.30
- Average True Range (ATR)
- ILAG 0.06
- ALBT 0.03
- MACD
- ILAG -0.01
- ALBT 0.00
- Stochastic Oscillator
- ILAG 16.32
- ALBT 26.09
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.